ZBIO Zenas Bio Total Asset Value of Company
This daily price chart of total assets for Zenas Biopharma Inc (ZBIO) shows a value of 497.36. Zenas Biopharma Inc (ZBIO) automates antibody purification via bioreactor systems, eliminating routine tasks for scientists. The business's profitability is based on supplying drugs to insurance funds for the therapy of autoimmune pathologies. The current development vector is focused on verifying the safety of bifunctional molecules as part of an early-phase trial portfolio expansion.
Analytical breakdowns and data insights for company Zenas Biopharma, Inc. (ZBIO)
- stock value and consensus price forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Zenas Biopharma Inc|ZBIO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Zenas Corp|ZBIO - Company Aggregate Debts|Debts to Book Capitalization Zenas Corp|ZBIO - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Zenas Biopharma|Interim Coverage Ratio zenasbio.com
- net income and valuation multiples indicators:
Fundamental valuation:Zenas Biopharma Inc
The complex process of developing proprietary antibodies at Zenas Biopharma Inc (ZBIO) requires colossal capital expenditures, which directly impacts the company's total resource value. This asset figure is reverse-calculated via return on assets (ROA), combining equity and liabilities to monitor the financial base between quarterly reports. Growth in this metric confirms the scale of expansion but may signal a decline in asset utilization efficiency.
Key competitors
Company Assets argenx.com (ARGX)|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|RIGL: Cumulative Company Assets|Total Asset Value of Company ANAB|ATXS: Company Total Assets|Company Assets engene.com (ENGN)|Aggregate Company Assets RAPT Therapeutics|Total Business Assets JBIO (Aerovate)|Company Total Assets ACRS|Company Total Assets Kyverna Therapeutics, Inc (KYTX)|Aggregate Company Assets Tiziana Life Sciences TLSA|Company Total Asset Base cabalettabio.com (CABA)|VTYX: Cumulative Company Assets|Aggregate Asset Value THTX (Theratechnologies, Inc.)|AVTX: Company Total Assets|ELDN (Eledon Pharmaceuticals, Inc) - Aggregate Company Assets|AGEN (Agenus) - Company Total Assets|climbbio.com (CLYM) - Company Total Asset Base|Aggregate Company Assets Zura Bio (ZURA)|ATYR - Company Assets|Aggregate Company Assets Adagene Inc. ADAG|IMA (ImageneBio) - Total Asset Value of Company|Shattuck Therapeutics - Company Total Assets|Aggregate Asset Value EQ (Equillium, Inc.)|CNTB: Company Total Assets|Immunic (IMUX) - Company Total Assets|Aggregate Company Assets Atara Biotherapeutics, Inc.|IFRX: Aggregate Asset Value|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|Cumulative Company Assets adicetbio.com ACET|Company Total Assets CELU (Celularity)|Company Total Assets INmune Bio Inc INMB|BRNS: Cumulative Company Assets|Aggregate Asset Value KZR (Kezar Life Sciences Inc)|SABS: Company Total Assets|AKTX - Company Total Asset Base|Aggregate Company Assets Enlivex Therapeutics Ltd|Total Business Assets QTTB (Q32 Bio Corp)|Company Total Assets GOVX|Cumulative Company Assets Edesa Biotech Corp EDSA|iBio, Inc. - Cumulative Company Assets|CARM (Carisma Therapeutics Inc) - Total Asset Value of Company|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT: Aggregate Company Assets|HCWB: Company Total Assets|APVO - Company Total Asset Base|Aggregate Company Assets AIM ImmunoTech Inc.|Company Assets Aditxt Corp ADTX|Aggregate Company Assets GRI Bio (GRI)|XRTX: Total Asset Value of Company|Company Total Assets HIND (ReShape Lifesciences)|Aggregate Asset Value REVB|Indaptus Therapeutics - Company Total Assets|SCNI - Company Total Assets|calcimedica.com (CALI) - Aggregate Company Assets|Affimed N.V. - Aggregate Asset Value|Aggregate Company Assets Allakos Inc|Cumulative Company Assets HOOKIPA (HOOK)|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com (ITOS)|Ocean Biomedical - Cumulative Company Assets|Aggregate Asset Value TCBP|Third Harmonic Bio, Inc - Company Total Assets